Sep 25, 2026 by Daniel SparksPrediction: Adobe Stock Trades Back Above $350 Before 2030Getting back there takes roughly a 12% annualized gain -- less than the earnings growth the company is already guiding for this year.
Sep 25, 2026 by Jeremy BowmanCostco Just Showed Why It's a Better Buy Than WalmartCostco delivered another strong earnings report, even as rivals like Walmart are seeing slowing revenue growth.
Sep 25, 2026 by Daniel SparksMeta Has Lost More Than $85 Billion on Its Glasses and Headsets. Here's What Would Stop It.What would it take to stop the losses in the social media giant's hardware unit?
Sep 25, 2026 by Maurie BackmanSocial Security's 2027 COLA Could Well Outpace This Year's Raise. Here's How Helpful It Might Actually Be.A larger raise may not end up being such a win.
Sep 25, 2026 by Keithen DruryIs SpaceX Stock a Buy, Sell, or Hold Right Now? Here's What I'm Doing.There are reasons to both buy and sell SpaceX stock.
Sep 25, 2026 by Daniel SparksPrediction: Adobe Stock Trades Back Above $350 Before 2030Getting back there takes roughly a 12% annualized gain -- less than the earnings growth the company is already guiding for this year.
Sep 25, 2026 by Robert IzquierdoBigBear.ai vs. Innodata: What Quarterly Revenue Trends Tell Investors About These Artificial Intelligence CompaniesInnodata's revenue has nearly doubled in two years while BigBear.ai has contracted, widening a gap that raises questions about competitive positioning.
Sep 25, 2026 by Jennifer SaibilWhere Will Robinhood Stock Be in 5 Years?The trading platform continues to launch the finance products of the future.
Sep 25, 2026 by Robert IzquierdoVanguard International ETF Face-Off: VXUS vs. VWOVXUS delivered 20.1% returns over one year while maintaining lower costs, but VWO's emerging-market focus offers distinct growth potential for risk-tolerant investors.
Sep 25, 2026 by Courtney CarlsenThe Math Doesn't Lie: What Oklo's Stock Sales Actually Cost InvestorsOklo could change the way we use nuclear energy. But getting there hasn't been cheap.
Sep 25, 2026 by Eric VolkmanMeet the 6 Categories That Drove Costco’s 19.5% Digitally Enabled Sales Comps in Its Latest Quarter.The growth figure was high, given how little the company hypes that channel.
Sep 25, 2026 by Jeremy BowmanCostco Just Showed Why It's a Better Buy Than WalmartCostco delivered another strong earnings report, even as rivals like Walmart are seeing slowing revenue growth.
Sep 25, 2026 by Selena Maranjian4 No-Brainer ETFs I'm Buying if the Stock Market Crashes in 2026These fast-growing ETFs will likely be trading at attractive valuations after a market pullback.
Sep 25, 2026 by Daniel SparksMeta Has Lost More Than $85 Billion on Its Glasses and Headsets. Here's What Would Stop It.What would it take to stop the losses in the social media giant's hardware unit?
Sep 25, 2026 by Jeremy BowmanNike and McDonald's Are the Worst-Performing Dow Stocks This Year. Here's the 1 to Buy in October.The brands share a similar association as titans of American export culture, and the two stocks are struggling now.
Sep 24, 2026 by Jeremy BowmanIs Micron Stock Going to $1,625? 1 Wall Street Analyst Think So. Micron still has plenty of upside potential.
Sep 24, 2026 by David DierkingIs VOO or VTI the Better Long-Term Investment? Here's What History Suggests.There's one key advantage that separates these two ETF industry heavyweights.
Sep 24, 2026 by John BallardAstera Labs vs. Marvell Technology: Which Tech Stock Is a Better Buy in 2026?Astera Labs boasts higher revenue growth, but customer concentration poses a risk. Marvell trades at lower multiples with broader diversification.
Sep 24, 2026 by Joe TenebrusoWhy Fervo Energy Stock Is Up TodayThe geothermal pioneer achieved a major operational milestone.
Sep 24, 2026 by Daniel SparksPrediction: The S&P 500 Finishes 2027 Above 9,000. Here's the Earnings Math.The prediction needs no richer valuation -- just one more year of double-digit earnings growth after 2027.
Sep 24, 2026 by Robert IzquierdoNova's Chief Technology Officer Dumps Nearly 4,000 Shares for $1.4 MillionThe CTO divested 15% of his direct holdings as the stock climbed 17% over the past year.
Sep 24, 2026 by Reuben Gregg BrewerIs Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?Revolution Medicines' stock is up 330% in a year on drug development progress; you may want to spread your bets with Royalty Pharma instead.
Sep 24, 2026 by Micah Zimmerman2 Soaring Stocks to Hold for the Next 7 YearsCoca-Cola and Costco may look like obvious picks, but a closer look reveals why both could still have plenty of room to grow over the next seven years.
